CRANBURY, N.J.--(BUSINESS WIRE)--Feb. 2, 2006--Valera Pharmaceuticals, Inc. today announced the pricing of its initial public offering of 3,750,000 shares of common stock at a price of $9.00 per share. Shares of Valera's common stock will trade on the Nasdaq National Market under the symbol "VLRX". Valera has granted the underwriters of this initial public offering a 30-day option to purchase up to an additional 562,500 shares at the public offering price. UBS Securities LLC and Banc of America Securities LLC served as joint book-running managers of the offering, and First Albany Capital, Inc. and Fortis Securities LLC served as co-managers.
